Ocimum Biosolutions launches Affymetrix services in Europe

Initially Ocimum will service gene expression studies on the Affymetrix platform from its facility at IJsselstein, The Netherlands. Within a couple of months, it will launch the entire bouquet of services from its IJsselstein facility.

Anu Acharya, CEO of Ocimum Biosolutions and Gene Logic, said: “Ocimum-Gene Logic is focused on providing high quality, validated and industry leading services to our clients worldwide. With the introduction of Affymetrix based genomics services in Europe, we are now available at the doorsteps of leading lifescience companies and research centers in Europe.

“Having replicated the same protocols which are used in our good laboratory practice compliant Gaithersburg facility, our European center would also now generate and analyze genomic and gene expression data with the same quality and attention to detail that make us the partner of choice for two-thirds of the top 25 pharmaceutical/biotech companies and research centers.”